tiprankstipranks
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
US Market
SXTP
60 Degrees Pharmaceuticals, Inc.
RESEARCH TOOLSreports
Want to see SXTP full AI Analyst Report?

60 Degrees Pharmaceuticals, Inc. (SXTP) Financial Statements

240 Followers

60 Degrees Pharmaceuticals, Inc. Financial Overview

60 Degrees Pharmaceuticals, Inc.'s market cap is currently $4.30M. The company's EPS TTM is $-1.91; its P/E ratio is -0.18; 60 Degrees Pharmaceuticals, Inc. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.01M$ 607.57K$ 253.57K$ 223.21K$ 1.16M
Gross Profit$ 223.78K$ 222.81K$ -220.98K$ -209.16K$ 309.60K
Operating Income$ -7.76M$ -9.71M$ -5.15M$ -1.75M$ -1.12M
EBITDA$ -7.28M$ -7.88M$ -1.43M$ -2.11M$ -1.01M
Net Income$ -7.37M$ -7.95M$ -3.77M$ -6.18M$ -4.25M
Balance Sheet
Cash & Short-Term Investments$ 2.75M$ 3.39M$ 2.14M$ 264.87K$ 115.40K
Total Assets$ 5.37M$ 5.76M$ 7.78M$ 1.30M$ 1.39M
Total Debt$ 152.78K$ 155.89K$ 172.67K$ 22.42M$ 18.80M
Net Debt$ -1.36M$ -1.50M$ -1.97M$ 22.15M$ 18.69M
Total Liabilities$ 1.99M$ 1.80M$ 2.99M$ 25.45M$ 19.55M
Stockholders' Equity$ 3.46M$ 4.04M$ 4.87M$ -23.58M$ -17.58M
Cash Flow
Free Cash Flow$ -7.07M$ -5.83M$ -4.66M$ -1.07M$ -684.50K
Operating Cash Flow$ -6.85M$ -5.65M$ -4.54M$ -1.01M$ -649.11K
Investing Cash Flow$ 254.92K$ -1.89M$ -115.89K$ -60.13K$ -35.39K
Financing Cash Flow$ 6.44M$ 7.05M$ 6.47M$ 1.22M$ 611.23K
Currency in USD

60 Degrees Pharmaceuticals, Inc. Earnings and Revenue History

Income Statement >

60 Degrees Pharmaceuticals, Inc. Debt to Assets

Balance Sheet >

60 Degrees Pharmaceuticals, Inc. Cash Flow

Cash Flow >

60 Degrees Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Earnings >